NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
December 15, 2020
vTv Therapeutics of High Point has out-licensed worldwide development and commercialization rights to its potential kidney disease drug to a California biotech company in a deal that ultimately could be worth more than $150 million.
December 14, 2020
Durham's BioSkryb is launching a grant program to secure a “breakthrough” in single-cell genomics using its proprietary technology, recently launched commercially as ResolveDNA.
December 11, 2020
Burlington-based LabCorp has received Emergency Use Authorization from the FDA to sell its COVID-19 test home collection kit, the first to be available over the counter without requiring a prescription.
December 11, 2020
Durham gene editing ag tech leader Elo Life Systems is using its proprietary computational biology pipeline to identify the genetic factors that can improve the vanilla orchid and introduce groundbreaking ways to produce more vanilla with less labor.
December 9, 2020
Thermo Fisher Scientific will invest approximately $500 million and add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines
December 9, 2020
Newly released Seqirus data demonstrate the effectiveness and safety of its pandemic influenza A (H5N1) vaccine that it makes in cell culture at its massive manufacturing facility in Holly Springs.
December 9, 2020
Southeastern North Carolina’s rural Scotland County community of Maxton is getting 10 new jobs and a $1.9 million expansion being added to the local Huvepharma factory, thanks in part to funding from NCBiotech.
December 9, 2020
Antifungal therapies developer Mycovia is preparing to seek FDA approval of its first drug after the compound posted
December 8, 2020
Chimerix, a Durham-based biopharmaceutical company that’s developing medicines to treat cancer and other diseases, has received good regulatory news for its potential antiviral treatment for smallpox.
December 7, 2020
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Durham-based BioCryst Pharmaceuticals’ berotralstat a positive scientific opinion through the Early Access to Medicines Scheme.
December 5, 2020
The FDA has approved a once-daily capsule developed by Durham's BioCryst Pharmaceuticals to prevent the life-threatening attacks of swelling in people with the rare disease called hereditary angioedema, or HAE.
December 2, 2020
An NCBiotech contract drug development and manufacturing portfolio company, KBI Biopharma, will establish a new $150M, 200-employee manufacturing facility near RTP.
December 1, 2020
North Carolina’s Small Business and Technology Development Center is hosting a two-day workshop for entrepreneurs starting Wednesday, Dec. 2
November 25, 2020
Former Duke University science educator and researcher and NCBiotech board member James (Jim) Siedow, Ph.D., has died.
November 25, 2020
Academic scientists at NC universities receive the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.